Kinetics and characteristics of replication-competent revertants derived from self-inactivating foamy virus vectors
- 19 February 2004
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 11 (5) , 465-473
- https://doi.org/10.1038/sj.gt.3302185
Abstract
In this study, self-inactivating (SIN) retroviral vectors based on feline foamy virus (FFV) were constructed and analysed. The FFV SIN vectors were devoid of the core FFV long terminal repeat promoter plus upstream sequences but contained all structural and regulatory genes. This design allowed sensitive detection of replication-competent revertants (RCRs). The FFV SIN vectors efficiently transduced the green fluorescence protein into recipient cells. However, RCRs appeared after serial passages of transduced cells. In all RCR clones analysed, parts of the heterologous cytomegalovirus immediate early promoter, originally driving expression of the FFV vector genome, were taken up to restore the deleted SIN promoter function required for replication competence. The RCRs were strongly reduced in replication capacity compared with the parental replication-competent vectors containing the FFV promoter. In all RCR genomes analysed, the uptake of the heterologous promoter was accompanied by deletion of almost the complete marker gene. Although the RCRs described in this study may not have the capacity to spread in humans and animals, they may pose a theoretical risk, for instance during transduction of haematopoietic stem cells. Thus, FV-based SIN vectors require additional genetic modifications in order to avoid RCRs.Keywords
This publication has 38 references indexed in Scilit:
- Application of Chimeric Feline Foamy Virus-Based Retroviral Vectors for the Induction of Antiviral Immunity in CatsJournal of Virology, 2003
- Progress and problems with the use of viral vectors for gene therapyNature Reviews Genetics, 2003
- Comparison of Three Retroviral Vector Systems for Transduction of Nonobese Diabetic/Severe Combined Immunodeficiency Mice Repopulating Human CD34+Cord Blood CellsHuman Gene Therapy, 2003
- Construction of a retroviral vector production system with the minimum possibility of a homologous recombinationGene Therapy, 2003
- Vector integration: Pest not guestGene Therapy, 2003
- Enhancer-deficient amphotropic murine leukemia virus and recombinants with heterologous transcription elements can be efficiently amplified and detected in Mus dunni fibroblastsGene Therapy, 2002
- Improved Primate Foamy Virus Vectors and Packaging ConstructsJournal of Virology, 2002
- Historical Perspective of Foamy Virus Epidemiology and InfectionClinical Microbiology Reviews, 2001
- Why aren’t foamy viruses pathogenic?Trends in Microbiology, 2000
- Regulation of gene expression by human foamy virus and potentials of foamy viral vectorsThe International Journal of Cell Cloning, 1997